25-NSE ·Filed May 11, 2026
Notable filing: 25-NSE
Actionable Insight • Neutral
No further trading on Nasdaq; shareholders who have not tendered shares should do so promptly. Monitor for any CVR valuation developments.
Latest settled — T+1d ⚠ clustered
KZR ▲ 0.00% at T+1d
NEUTRAL call ✗ call lost 0.00% · α vs SPY +0.14% · entry $7.29 → $7.29
T+1d
0.00%
call 0.00% · α +0.14%
$7.29
settled 5mo ago
T+5d
—
call — · α —
—
due 5mo ago
T+20d
—
call — · α —
—
due 4mo ago
T+60d
—
call — · α —
—
due 8w ago
Price Chart
Loading chart...
Executive Summary
Nasdaq filed a 25-NSE notification to remove Kezar Life Sciences' common stock from listing, effective immediately. This follows the completion of Aurinia Pharma's acquisition of Kezar on the same day, in which shareholders received $6.955 per share plus contingent value rights.
Key Facts
- Delisting effective May 11, 2026 per Rule 12d2-2(a)(3).
- Acquisition by Aurinia Pharma U.S., Inc. completed prior to delisting; shareholders received $6.955 per share plus one CVR per share.
- Kezar is now a wholly owned subsidiary of Aurinia.
Financial Impact
Shareholders received $6.955 per share in cash plus contingent value rights; no further trading expected.
stock price
Risk Factors
- CVR may pay out less than anticipated or nothing.
- Potential for shareholder litigation if acquisition process challenged.
- Loss of liquidity as stock is delisted.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
44% bullish (9 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000433 |
| Document: 0001354457-26-000433-index-headers.html | 0001354457-26-000433 |
| Document: 0001354457-26-000433-index.html | 0001354457-26-000433 |
| Document: 0001354457-26-000433.txt | 0001354457-26-000433 |
3 reports for KZR
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
May 15, 2026 20w ago | EFFECT | $7.29 awaiting T+1 | awaiting T+1 | — | — |
May 11, 2026 20w ago | 25-NSE | $7.29 $7.29 | · 0.00% | ▲ +0.14% | — |
May 11, 2026 20w ago | 8-K | $7.29 $7.29 | · 0.00% | ▲ +0.14% | — |
Showing 3 of 3
US Market Status
Market Closed — Opens Mon (64h 21m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access